All good, I can change my statement to BMT-CTN will cover most of the trial costs.
Mesoblast will only pay 6-9mil for their share of the Adult aGHVD trial.
Peanuts for Mesoblast's share of costs to achieve a full trial and plenty of money still left in the bank after 6 to 9 mil cost.
I agree with you that Si believes there is also more cash coming in soonish - next 6 months from some type partnership/commercial sales transaction(s). Bring that on.
Si did seem to have a lot of confidence today on the company progression and achievements of these trials completing.
Ann: Half Year Report and Accounts (including Appendix 4D), page-20
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |